CHAMPIONS ONCOLOGY, INC.
For the period ended Aug 27, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 27, 2026 · Filed Aug 28, 2026
CSBR$4.79+0.6%Stored close · as of Nov 6, 2026
Contents
Independence of Directors
The Company's Board of Directors has determined that Messrs. Ackerman, Sidransky, Mendelson, Tobin, and Alexander are “independent” as defined in Rule 5605(a)(2) of the Nasdaq Stock Market Rules (“Nasdaq Rules”). The Company's Board of Directors currently consists of five independent directors and two non-independent directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.